Stemline Therapeutics Inc (STML) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

United States, 25 pages report, published by GlobalData

Report ThumbnailAugust-2017
Summary

Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pipeline comprise SL-401, SL-701, SL-801, SL-501 and SL-101. Stemline's SL-401 is a targeted therapy directed to the interleukin-3 receptor (IL-3R) present on CSCs and tumor bulk of hematologic cancers

Read More
  • List of Figures
  • Stemline Therapeutics Inc, Performance Chart
  • Stemline Therapeutics Inc, Ratio Charts
Read More
  • List of Tables
  • Stemline Therapeutics Inc, Key Information
  • Stemline Therapeutics Inc, Key Ratios
  • Stemline Therapeutics Inc, Share Data
  • Stemline Therapeutics Inc, Major Products and Services
  • Stemline Therapeutics Inc, History
  • Stemline Therapeutics Inc, Key Employees
  • Stemline Therapeutics Inc, Key Employee Biographies
  • Stemline Therapeutics Inc, Key Operational Heads
  • Stemline Therapeutics Inc, Other Locations
  • Stemline Therapeutics Inc, Subsidiaries
  • Stemline Therapeu
Read More
  • Table of Contents
  • Section 1 - About the Company
  • Stemline Therapeutics Inc - Key Information
  • Stemline Therapeutics Inc - Overview
  • Stemline Therapeutics Inc - Key Employees
  • Stemline Therapeutics Inc - Key Employee Biographies
  • Stemline Therapeutics Inc - Key Operational Heads
  • Stemline Therapeutics Inc - Major Products and Services
  • Stemline Therapeutics Inc - History
  • Stemline Therapeutics Inc - Company Statement
  • Stemline Therapeutics Inc - Locations And Subsidiaries
Read More

Please select a license type

Share

Related Products

GlobalDataStemline Therapeutics Inc (STML) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailStemline Therapeutics Inc (STML) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 679741
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved